Literature DB >> 23801170

SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.

Thomas C Kwee1, Gang Cheng, Marnix G E H Lam, Sandip Basu, Abass Alavi.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23801170     DOI： 10.1007/s00259-013-2484-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

1.  Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

2.  Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET.

Authors:  Sandip Basu; Thomas C Kwee; Drew Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-18       Impact factor: 9.236

3.  FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy.

Authors:  A D Beggs; S F Hain; K M Curran; M J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02-27       Impact factor: 9.236

Review 4.  A new dimension of FDG-PET interpretation: assessment of tumor biology.

Authors:  Thomas C Kwee; Sandip Basu; Babak Saboury; Valentina Ambrosini; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

5.  Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

Authors:  Marc Hickeson; Mijin Yun; Alexander Matthies; Hongming Zhuang; Lars-Eric Adam; Lester Lacorte; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-02       Impact factor: 9.236

6.  FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy.

Authors:  S F Hain; K M Curran; A D Beggs; I Fogelman; M J O'Doherty; M N Maisey
Journal:  Eur J Nucl Med       Date:  2001-09

7.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

8.  Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.

Authors:  Erik S Musiek; Babak Saboury; Shipra Mishra; Yufen Chen; Janet S Reddin; Andrew B Newberg; Jayaram K Udupa; John A Detre; Frank Hofheinz; Drew Torigian; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2012-10-25       Impact factor: 1.102

Review 9.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.

Authors:  P D Shreve; Y Anzai; R L Wahl
Journal:  Radiographics       Date:  1999 Jan-Feb       Impact factor: 5.333

10.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Authors:  Ronald Boellaard; Mike J O'Doherty; Wolfgang A Weber; Felix M Mottaghy; Markus N Lonsdale; Sigrid G Stroobants; Wim J G Oyen; Joerg Kotzerke; Otto S Hoekstra; Jan Pruim; Paul K Marsden; Klaus Tatsch; Corneline J Hoekstra; Eric P Visser; Bertjan Arends; Fred J Verzijlbergen; Josee M Zijlstra; Emile F I Comans; Adriaan A Lammertsma; Anne M Paans; Antoon T Willemsen; Thomas Beyer; Andreas Bockisch; Cornelia Schaefer-Prokop; Dominique Delbeke; Richard P Baum; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236
View more
  15 in total

1.  18F-FDG PET-derived parameters as prognostic indices in hepatic malignancies after 90Y radioembolization: is there a role?

Authors:  Oreste Bagni; Luca Filippi; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-05       Impact factor: 9.236

2.  The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.

Authors:  Wendi O'Connor; Megan Quintana; Scott Smith; Monte Willis; Jordan Renner
Journal:  J Radiol Case Rep       Date:  2014-06-30

Review 3.  Imaging of solitary pulmonary nodule-a clinical review.

Authors:  Yee Ting Sim; Fat Wui Poon
Journal:  Quant Imaging Med Surg       Date:  2013-12

4.  Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology.

Authors:  Abass Alavi; Thomas J Werner; Poul Flemming Høilund-Carlsen; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

5.  Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours.

Authors:  Luca Filippi; Francesco Scopinaro; Giuseppe Pelle; Roberto Cianni; Rita Salvatori; Orazio Schillaci; Oreste Bagni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-02       Impact factor: 9.236

6.  Advantages of 18F FDG-PET/CT over Conventional Staging for Sarcoma Patients.

Authors:  Zsuzsanna Németh; Katalin Boér; Katalin Borbély
Journal:  Pathol Oncol Res       Date:  2017-10-09       Impact factor: 3.201

Review 7.  Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Brigid McDonald; Mary Gronberg; Grete May Engeseth; Renjie He; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-09-17       Impact factor: 3.722

8.  Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules.

Authors:  Eugene J Teoh; Daniel R McGowan; Kevin M Bradley; Elizabeth Belcher; Edward Black; Fergus V Gleeson
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

9.  18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.

Authors:  Eugene J Teoh; Daniel R McGowan; Kevin M Bradley; Elizabeth Belcher; Edward Black; Alastair Moore; Annemarie Sykes; Fergus V Gleeson
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

10.  Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.

Authors:  Eugene J Teoh; Daniel R McGowan; Ruth E Macpherson; Kevin M Bradley; Fergus V Gleeson
Journal:  J Nucl Med       Date:  2015-07-09       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.